Scinai Immunotherapeutics Cash Flow Statement (2014-2026) | SCNI

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Mar2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-2.46M-11.99M-9.05M12.39M-1.50M-3.00M-6.14M-19.78M3.52M3.76M-11.45M-1.93M-2.16M6.64M-2.42M-3.64M-1.57M-2.19M-2.47M
Depreciation and Depletion (Quarter)
0.18M0.60M0.61M-0.09M
Share-based Compensation (Quarter)
0.44M2.58M2.53M0.73M0.48M0.11M0.33M0.40M0.25M0.20M0.23M0.45M0.19M0.14M0.14M0.47M0.32M0.07M
Gains from Investment Securities (Quarter)
-2.57M-0.77M-0.59M-0.22M-0.10M0.00M-1.56M3.58M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)
0.90M5.60M1.58M1.09M
Change in Working Capital (Quarter)
Change in Receivables (Quarter)
0.22M1.22M-1.51M0.14M-0.13M-0.09M0.37M0.15M-0.04M-0.00M-0.03M0.05M-0.07M-0.02M
Change in Account Payables (Quarter)
0.07M0.55M0.68M0.20M0.08M-0.40M-0.26M0.89M0.63M-0.66M-0.10M-0.01M0.31M-0.18M-0.23M-0.05M0.17M0.11M0.20M
Change in Accured Expenses (Quarter)
0.12M-0.61M0.79M-0.37M0.02M-0.23M-0.24M0.04M-0.05M0.06M-0.10M0.35M
Other Working Capital Changes (Quarter)
0.01M-0.14M-0.02M0.00M0.00M-0.03M0.07M0.11M0.06M-0.53M0.07M-0.04M0.11M
Cash from Operations (Quarter)
-1.16M-7.91M-6.19M-1.86M-1.10M-3.67M-1.90M-0.59M-3.06M-2.88M-2.22M-1.23M-1.46M-1.76M-2.04M-1.08M-1.04M-1.53M-1.46M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.18M0.60M0.61M-0.09M0.13M0.14M0.10M0.18M0.14M0.15M0.14M0.08M0.16M0.50M0.50M0.50M0.35M0.35M0.45M
Investing Activities
Capital Expenditures (Quarter)
-0.01M-0.11M-0.00M0.18M0.52M-0.04M-0.08M1.40M-0.01M-0.38M-0.02M1.04M-0.00M-0.01M-0.00M0.02M-0.01M-0.00M-0.00M
Acquisitions (Quarter)
-2.98M10.80M-3.29M-1.14M4.83M-1.75M-2.04M1.02M-0.03M2.75M
Cash from Investing Activities (Quarter)
0.00M-0.11M-0.01M-0.11M-0.52M-0.08M-0.08M-0.27M-0.01M-0.38M-0.02M-0.23M0.00M-0.01M0.02M-0.02M0.01M-0.02M2.75M
Financing Activities
Other financing activities (Quarter)
-0.00M5.71M0.13M-0.00M-0.00M0.82M1.42M0.01M0.01M0.13M0.01M0.15M
Cash from Financing Activities (Quarter)
12.54M-0.32M-0.99M8.88M-0.47M1.42M0.01M0.01M2.00M0.10M1.48M0.01M
Change in Capital Stock
Net Shares Issued and Repurchased (Quarter)
Net Equity Issued and Repurchased (Quarter)
12.64M29.49M-0.68M8.59M-0.95M
Additional items
Exchange Rate Effect (Quarter)
0.36M-0.36M1.98M-0.29M-0.36M1.57M-0.99M-0.15M-0.22M-0.04M0.01M-0.01M4.97M-4.84M-0.13M0.00M1.15M-1.11M3.11M
Change in Cash (Quarter)
11.74M-8.69M-5.21M6.62M-1.99M-9.35M-2.97M5.76M-3.29M-3.29M-1.15M-1.47M-0.04M-1.87M-1.92M0.93M-0.95M-0.02M1.30M
Free Cash Flow (Quarter)
-1.15M-7.80M-6.18M-2.04M-1.63M-3.62M-1.82M-2.00M-3.05M-2.50M-2.20M-2.27M-1.46M-1.75M-2.03M-1.10M-1.03M-1.53M-1.45M
Net Cash Flow (Quarter)
11.39M-8.33M-7.19M6.91M-1.63M-4.22M-1.98M-0.86M-3.06M-3.25M-2.24M-1.46M-0.04M-1.76M-2.01M0.90M-0.93M-0.08M1.30M